Comments: US SB2665 | 2017-2018 | 115th Congress

Bill Title: A bill to require guidance on how the Food and Drug Administration will consider claims of opioid sparing and on the conditions under which the Food and Drug Administration will consider misuse and abuse of drugs in making certain determinations of safety.

Spectrum: Bipartisan Bill

Status: (Introduced - Dead) 2018-04-12 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. [SB2665 Detail]

Text: Latest bill text (Introduced) [PDF]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2017 US Congress SB2665 at this time.

Social Comments on US SB2665

feedback